Table 3.
The variable importance from the Random Forest in predicting metabolic syndrome.
All participants | Value | Rank | CVD undiagnosed | Value | Rank | CVD diagnosed | Value | Rank | |||
---|---|---|---|---|---|---|---|---|---|---|---|
v030 | BMI | 0.1032 | 1 | v030 | BMI | 0.1266 | 1 | v030 | BMI | 0.1177 | 1 |
v090 | Antihypertensive drug | 0.0552 | 2 | v005 | Age | 0.0453 | 2 | v036 | WBC counts (Thous/µL) | 0.0459 | 2 |
v053 | Hypertension | 0.0499 | 3 | v036 | WBC counts (Thous/µL) | 0.0353 | 3 | v075 | LDL | 0.0379 | 3 |
v049 | CVD | 0.0453 | 4 | v075 | LDL | 0.0330 | 4 | v031 | Total cholesterol (mg/dL) | 0.0299 | 4 |
v005 | Age | 0.0437 | 5 | v014 | Subjective body image | 0.0316 | 5 | v091 | Lipid-lowering agent | 0.0274 | 5 |
v036 | WBC counts (Thous/µL) | 0.0297 | 6 | v031 | Total cholesterol (mg/dL) | 0.0303 | 6 | v037 | RBC counts (Mil/µL) | 0.0260 | 6 |
v075 | LDL | 0.0263 | 7 | v037 | RBC counts (Mil/µL) | 0.0302 | 7 | v041 | Daily intake of fat (g) | 0.0256 | 7 |
v076 | Menstrual status | 0.0247 | 8 | v033 | Hematocrit (%) | 0.0263 | 8 | v014 | Subjective body image | 0.0252 | 8 |
v091 | Lipid-lowering agent | 0.0237 | 9 | v041 | Daily intake of fat (g) | 0.0255 | 9 | v046 | Daily intake of sodium (mg) | 0.0250 | 9 |
v037 | RBC counts (Mil/µL) | 0.0231 | 10 | v032 | Hemoglobin (g/dL) | 0.0251 | 10 | v005 | Age | 0.0250 | 10 |
v031 | Total cholesterol (mg/dL) | 0.0229 | 11 | v039 | Daily intake of water (g) | 0.0242 | 11 | v043 | Daily intake of calcium (mg) | 0.0249 | 11 |
v014 | Subjective body image | 0.0221 | 12 | v046 | Daily intake of sodium (mg) | 0.0239 | 12 | v048 | Daily intake of vitamin C (mg) | 0.0246 | 12 |
v007 | Education level | 0.0214 | 13 | v048 | Daily intake of vitamin C (mg) | 0.0237 | 13 | v039 | Daily intake of water (g) | 0.0244 | 13 |
v041 | Daily intake of fat (g) | 0.0198 | 14 | v082 | BF durations (month) | 0.0235 | 14 | v042 | Daily intake of carbohydrate (g) | 0.0240 | 14 |
v033 | Hematocrit (%) | 0.0197 | 15 | v035 | Serum creatinine (mg/dL) | 0.0233 | 15 | v033 | Hematocrit (%) | 0.0236 | 15 |
v082 | BF duration (month) | 0.0191 | 16 | v043 | Daily intake of calcium (mg) | 0.0231 | 16 | v038 | Daily intake of calories (kcal) | 0.0234 | 16 |
v092 | Drug treatment for glucose control | 0.0190 | 17 | v042 | Daily intake of carbohydrate (g) | 0.0230 | 17 | v035 | Serum creatinine (mg/dL) | 0.0234 | 17 |
v032 | Hemoglobin (g/dL) | 0.0186 | 18 | v045 | Daily intake of iron (mg) | 0.0227 | 18 | v045 | Daily intake of iron (mg) | 0.0233 | 18 |
v039 | Daily intake of water (g) | 0.0186 | 19 | v040 | Daily intake of protein (g) | 0.0223 | 19 | v040 | Daily intake of protein (g) | 0.0231 | 19 |
v048 | Daily intake of vitamin C (mg) | 0.0184 | 20 | v038 | Daily intake of calories (kcal) | 0.0222 | 20 | v047 | Daily intake of potassium (mg) | 0.0231 | 20 |
v046 | Daily intake of sodium (mg) | 0.0183 | 21 | v047 | Daily intake of potassium (mg) | 0.0222 | 21 | v044 | Daily intake of phosphorus (mg) | 0.0228 | 21 |
v043 | Daily intake of calcium (mg) | 0.0181 | 22 | v044 | Daily intake of phosphorus (mg) | 0.0218 | 22 | v092 | Drug treatment for glucose control | 0.0225 | 22 |
v035 | Serum creatinine (mg/dL) | 0.0180 | 23 | v007 | Education level | 0.0196 | 23 | v032 | Hemoglobin (g/dL) | 0.0218 | 23 |
v042 | Daily intake of carbohydrate (g) | 0.0177 | 24 | v034 | Blood urea nitrogen (mg/dL) | 0.0188 | 24 | v034 | Blood urea nitrogen (mg/dL) | 0.0204 | 24 |
v045 | Daily intake of iron (mg) | 0.0173 | 25 | v077 | Age at menarche (years) | 0.0170 | 25 | v094 | Oral hypoglycemic agents | 0.0204 | 25 |
v047 | Daily intake of potassium (mg) | 0.0172 | 26 | v083 | Gravidity | 0.0159 | 26 | v082 | BF durations (month) | 0.0196 | 26 |
v040 | Daily intake of protein (g) | 0.0172 | 27 | v076 | Menstrual status | 0.0158 | 27 | v093 | Insulin | 0.0193 | 27 |
v038 | Daily intake of calories (kcal) | 0.0172 | 28 | v092 | Drug treatment for glucose control | 0.0153 | 28 | v002 | Age at enrollment (years) | 0.0158 | 28 |
v094 | Oral hypoglycemic agents | 0.0171 | 29 | v094 | Oral hypoglycemic agents | 0.0152 | 29 | v077 | Age at menarche (years) | 0.0153 | 29 |
v044 | Daily intake of phosphorus (mg) | 0.0171 | 30 | v002 | Age at enrollment (years) | 0.0148 | 30 | v011 | EQ-5D | 0.0146 | 30 |
v093 | Insulin | 0.0171 | 31 | v093 | Insulin | 0.0139 | 31 | v083 | Gravidity | 0.0144 | 31 |
v034 | Blood urea nitrogen (mg/dL) | 0.0154 | 32 | v081 | Number of breastfed children | 0.0137 | 32 | v090 | Antihypertensive drug | 0.0125 | 32 |
v077 | Age at menarche (years) | 0.0136 | 33 | v091 | Lipid-lowering agent | 0.0130 | 33 | v081 | Number of breastfed children | 0.0123 | 33 |
v083 | Gravidity | 0.0135 | 34 | v052 | Frequency of drinking per year | 0.0127 | 34 | v052 | Frequency of drinking per year | 0.0119 | 34 |
v081 | Number of breastfed children | 0.0128 | 35 | v011 | EQ-5D | 0.0124 | 35 | v007 | Education level | 0.0100 | 35 |
v011 | EQ-5D | 0.0119 | 36 | v006 | Household income | 0.0107 | 36 | v006 | Household income | 0.0093 | 36 |
v002 | Age at enrollment (years) | 0.0116 | 37 | v013 | Occupation | 0.0098 | 37 | v016 | Weight control in the last 1 year | 0.0087 | 37 |
v052 | Frequency of drinking per year | 0.0100 | 38 | v016 | Weight control in the last 1 year | 0.0080 | 38 | v017 | Stress awareness | 0.0084 | 38 |
v006 | Household income | 0.0092 | 39 | v017 | Stress awareness | 0.0078 | 39 | v013 | Occupation | 0.0080 | 39 |
v013 | Occupation | 0.0072 | 40 | v015 | Weight change in the last 1 year | 0.0061 | 40 | v015 | Weight change in the last 1 year | 0.0056 | 40 |
v016 | Weight control in the last 1 year | 0.0067 | 41 | v018 | The days of weight training per week | 0.0054 | 41 | v018 | The days of weight training per week | 0.0048 | 41 |
v017 | Stress awareness | 0.0061 | 42 | v057 | Osteoarthritis | 0.0040 | 42 | v009 | Participation in health examination | 0.0040 | 42 |
v057 | Osteoarthritis | 0.0049 | 43 | v010 | Cancer screening for the last 2 years | 0.0039 | 43 | v021 | Diagnosis of HTN in mother | 0.0039 | 43 |
v015 | Weight change in the last 1 year | 0.0044 | 44 | v012 | Economic activity | 0.0038 | 44 | v057 | Osteoarthritis | 0.0038 | 44 |
v018 | The days of weight training per week | 0.0041 | 45 | v009 | Participation in health examination | 0.0037 | 45 | v010 | Cancer screening for the last 2 years | 0.0037 | 45 |
v010 | Cancer screening for the last 2 years | 0.0030 | 46 | v051 | Smoking | 0.0035 | 46 | v053 | Hypertension | 0.0037 | 46 |
v009 | Participation in health examination | 0.0029 | 47 | v021 | Diagnosis of HTN in mother | 0.0035 | 47 | v012 | Economic activity | 0.0036 | 47 |
v012 | Economic activity | 0.0028 | 48 | v003 | Residental area (urban/rural) | 0.0034 | 48 | v019 | Use of oral contraceptive | 0.0036 | 48 |
v003 | Residental area (urban/rural) | 0.0027 | 49 | v029 | Diagnosis of DM in mother | 0.0032 | 49 | v003 | Residental area (urban/rural) | 0.0036 | 49 |
v019 | Use of oral contraceptive | 0.0026 | 50 | v019 | Use of oral contraceptive | 0.0032 | 50 | v076 | Menstrual status | 0.0035 | 50 |
v021 | Diagnosis of HTN in mother | 0.0026 | 51 | v020 | Diagnosis of HTN in father | 0.0027 | 51 | v062 | Depression | 0.0032 | 51 |
v051 | Smoking | 0.0023 | 52 | v074 | Melancholy in the last 1 year | 0.0027 | 52 | v020 | Diagnosis of HTN in father | 0.0030 | 52 |
v020 | Diagnosis of HTN in father | 0.0022 | 53 | v062 | Depression | 0.0026 | 53 | v074 | Melancholy in the last 1 year | 0.0029 | 53 |
v074 | Melancholy in the last 1 year | 0.0021 | 54 | v028 | Diagnosis of DM in father | 0.0024 | 54 | v027 | Diagnosis of stroke in mother | 0.0026 | 54 |
v080 | History of breastfeeding | 0.0021 | 55 | v080 | History of breastfeeding | 0.0023 | 55 | v026 | Diagnosis of stroke in father | 0.0025 | 55 |
v062 | Depression | 0.0020 | 56 | v027 | Diagnosis of stroke in mother | 0.0021 | 56 | v051 | Smoking | 0.0025 | 56 |
v029 | Diagnosis of DM in mother | 0.0020 | 57 | v026 | Diagnosis of stroke in father | 0.0020 | 57 | v056 | Stroke | 0.0024 | 57 |
v027 | Diagnosis of stroke in mother | 0.0017 | 58 | v061 | Thyroid disease | 0.0020 | 58 | v055 | angina | 0.0023 | 58 |
v079 | Childbirth experience | 0.0017 | 59 | v079 | Childbirth experience | 0.0018 | 59 | v061 | Thyroid disease | 0.0022 | 59 |
v026 | Diagnosis of stroke in father | 0.0016 | 60 | v008 | Marriage | 0.0017 | 60 | v058 | Rheumatic arthritis | 0.0020 | 60 |
v028 | Diagnosis of DM in father | 0.0016 | 61 | v060 | Asthma | 0.0017 | 61 | v029 | Diagnosis of DM in mother | 0.0020 | 61 |
v061 | Thyroid disease | 0.0015 | 62 | v078 | Pregnancy experience | 0.0015 | 62 | v080 | History of breastfeeding | 0.0019 | 62 |
v078 | Pregnancy experience | 0.0013 | 63 | v059 | Tuberculosis | 0.0014 | 63 | v059 | Tuberculosis | 0.0019 | 63 |
v008 | Marriage | 0.0012 | 64 | v064 | Atopic dermatitis | 0.0012 | 64 | v060 | Asthma | 0.0015 | 64 |
v060 | Asthma | 0.0012 | 65 | v024 | Diagnosis of IHD in father | 0.0012 | 65 | v028 | Diagnosis of DM in father | 0.0013 | 65 |
v059 | Tuberculosis | 0.0011 | 66 | v058 | Rheumatic arthritis | 0.0012 | 66 | v025 | Diagnosis of IHD in mother | 0.0011 | 66 |
v058 | Rheumatic arthritis | 0.0011 | 67 | v023 | Diagnosis of hyperlipidemia in mother | 0.0012 | 67 | v023 | Diagnosis of hyperlipidemia in mother | 0.0010 | 67 |
v056 | Stroke | 0.0011 | 68 | v025 | Diagnosis of IHD in mother | 0.0011 | 68 | v079 | Childbirth experience | 0.0009 | 68 |
v023 | Diagnosis of hyperlipidemia in mother | 0.0009 | 69 | v056 | Stroke | 0.0010 | 69 | v064 | Atopic dermatitis | 0.0008 | 69 |
v024 | Diagnosis of IHD in father | 0.0009 | 70 | v068 | Breast cancer | 0.0006 | 70 | v054 | Myocardial infarction | 0.0008 | 70 |
v055 | Angina | 0.0009 | 71 | v022 | Diagnosis of hyperlipidemia in father | 0.0006 | 71 | v065 | Gastric cancer | 0.0007 | 71 |
v025 | Diagnosis of IHD in mother | 0.0008 | 72 | v069 | Cervical cancer | 0.0005 | 72 | v024 | Diagnosis of IHD in father | 0.0006 | 72 |
v064 | Atopic dermatitis | 0.0007 | 73 | v071 | Hepatitis B | 0.0004 | 73 | v078 | Pregnancy experience | 0.0006 | 73 |
v068 | Breast cancer | 0.0005 | 74 | v067 | Colon cancer | 0.0004 | 74 | v069 | Cervical cancer | 0.0006 | 74 |
v069 | Cervical cancer | 0.0004 | 75 | v072 | Hepatitis C | 0.0002 | 75 | v068 | Breast cancer | 0.0006 | 75 |
v022 | Diagnosis of hyperlipidemia in father | 0.0004 | 76 | v073 | Liver cirrhosis | 0.0001 | 76 | v073 | Liver cirrhosis | 0.0005 | 76 |
v071 | Hepatitis B | 0.0004 | 77 | v065 | Gastric cancer | 0.0001 | 77 | v008 | Marriage | 0.0005 | 77 |
v067 | Colon cancer | 0.0003 | 78 | v063 | Chronic kidney disease | 0.0001 | 78 | v071 | Hepatitis B | 0.0005 | 78 |
v065 | Gastric cancer | 0.0003 | 79 | v070 | Lung cancer | 0.0001 | 79 | v063 | Chronic kidney disease | 0.0005 | 79 |
v054 | Myocardial infarction | 0.0003 | 80 | v066 | Liver cancer | 0.0000 | 80 | v067 | Colon cancer | 0.0003 | 80 |
v073 | Liver cirrhosis | 0.0002 | 81 | v004 | Sex | 0.0000 | 81 | v022 | Diagnosis of hyperlipidemia in father | 0.0003 | 81 |
v063 | Chronic kidney disease | 0.0002 | 82 | v049 | CVD | 0.0000 | 81 | v072 | Hepatitis C | 0.0002 | 82 |
v072 | Hepatitis C | 0.0002 | 83 | v053 | Hypertension | 0.0000 | 81 | v070 | Lung cancer | 0.0001 | 83 |
v070 | Lung cancer | 0.0001 | 84 | v054 | Myocardial infarction | 0.0000 | 81 | v066 | Liver cancer | 0.0000 | 84 |
v066 | Liver cancer | 0.0000 | 85 | v055 | Angina | 0.0000 | 81 | v004 | Sex | 0.0000 | 85 |
v004 | Sex | 0.0000 | 86 | v090 | Antihypertensive drug | 0.0000 | 81 | v049 | CVD | 0.0000 | 85 |
TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body mass index; IHD, ischemic heart disease; DM, diabetes mellitus; HTN, hypertension; WBC, white blood cell; CVD, cardiovascular disease; RBC, red blood cell; EQ-5D, European Quality of Life-5 Dimension.